GDS Wealth Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Buy
125,608
+15,486
+14% +$1.27M 0.63% 62
2025
Q4
$10.1M Buy
110,122
+9,153
+9% +$876K 0.63% 61
2025
Q3
$9.57M Buy
100,969
+13,682
+16% +$1.29M 0.63% 67
2025
Q2
$9.14M Buy
87,287
+19,280
+28% +$1.83M 0.67% 65
2025
Q1
$6.01M Buy
68,007
+26,876
+65% +$2.76M 0.51% 63
2024
Q4
$3.95M Buy
41,131
+12,493
+44% +$1.16M 0.36% 57
2024
Q3
$2.34M Buy
+28,638
New +$2.21M 0.23% 56

Other funds holding HQY

GDS Wealth Management's HQY Position: Q1 2026 in Review

GDS Wealth Management increased its HealthEquity (HQY) stake by 14% in Q1 2026, buying an estimated $1.27M and bringing the position to 125,608 shares worth $10.5M. The position accounts for 0.63% of the portfolio, ranked #62.

GDS Wealth Management first reported a position in HQY in Q3 2024 and has held it in 7 quarters since. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • GDS Wealth Management held 125,608 shares of HealthEquity worth $10.5M as of Q1 2026.
  • GDS Wealth Management bought 15,486 HealthEquity shares in Q1 2026, an estimated $1.27M.
  • HealthEquity made up 0.63% of GDS Wealth Management's portfolio in Q1 2026, its #62 holding.
  • GDS Wealth Management first reported a position in HealthEquity in Q3 2024 and has held it in 7 quarters since.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on GDS Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.